CDKN2A and acute lymphoblastic leukemia: The CDKN2A/2B deletions are the most frequent CNAs in pediatric ALL, with most published studies reporting incidence rates of 20–25% in B-cell-precursor (BCP) ALL and 38.5–50% in T-ALL cases [17,18,19,21].